FDA approves first generic drug to receive CGT designation
The FDA on Wednesday approved several versions of Apotex’s potassium chloride oral solution as the first generic drugs to receive a Competitive Generic Therapy (CGT) designation.
Thanks to the FDA Reauthorization Act of 2017 (FDARA), the CGT designation allows generic drugs to come to market faster than they otherwise would have, but only in cases where there is one approved competitor generic drug in the active section of the Orange Book.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.